RBC Bioscience (ROCO:6848) OCF Margin %: 29.00% (As of Dec. 2025) — 122% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6848 RBC Bioscience Corp ROCO:6848
76 GF Score
Price NT$20.50
GF Value NT$19.91
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is RBC Bioscience OCF Margin %?

RBC Bioscience ROCO:6848 +4.86% 76 OCF Margin % is 29.00% as of Dec. 2025, which is 122% above its 10-year median of 13.05. GuruFocus rates ROCO:6848 with a GF Score™ of 76/100 and a GF Value™ of NT$19.91 (Fairly Valued). The stock has 7 warning signs investors should review. Among 950 Biotechnology companies, RBC Bioscience ranks better than 82.63% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. RBC Bioscience's Cash Flow from Operations for the six months ended in Dec. 2025 was NT$32.5 Mil. RBC Bioscience's Revenue for the six months ended in Dec. 2025 was NT$112.0 Mil. Therefore, RBC Bioscience's OCF Margin % for the quarter that ended in Dec. 2025 was 29.00%.

As of today, RBC Bioscience's current OCF Yield % is 14.52%.

The historical rank and industry rank for RBC Bioscience's OCF Margin % or its related term are showing as below:

ROCO:6848' s OCF Margin % Range Over the Past 10 Years
Min: -10.07   Med: 13.05   Max: 35.76
Current: 18.44

During the past 9 years, the highest OCF Margin % of RBC Bioscience was 35.76%. The lowest was -10.07%. And the median was 13.05%.

ROCO:6848's OCF Margin % is ranked better than
82.63% of 950 companies
in the Biotechnology industry
Industry Median: -64.565 vs ROCO:6848: 18.44

RBC Bioscience OCF Margin % Related Terms

RBC Bioscience OCF Margin % Historical Data

* Premium members only.

The historical data trend for RBC Bioscience's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Bioscience OCF Margin % Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only -10.07 3.80 7.66 27.25 18.44

RBC Bioscience Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.19 22.96 32.31 7.46 29.00

ROCO:6848 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, RBC Bioscience's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RBC Bioscience OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RBC Bioscience's OCF Margin % distribution charts can be found below:

* The bar in red indicates where RBC Bioscience's OCF Margin % falls into.


ROCO:6848
76GF Score
RBC Bioscience Corp ROCO:6848
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RBC Bioscience OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

RBC Bioscience's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=40.519/219.707
=18.44 %

RBC Bioscience's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=32.487/112.011
=29.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 29.00% mean?
RBC Bioscience (ROCO:6848) has a OCF Margin % of 29.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on RBC Bioscience and its competitors. This is 122% above median its historical median of 13.05. According to the industry distribution chart, RBC Bioscience ranks #165 out of 950 companies in the Biotechnology industry, placing it in the top 17.4%.
Is RBC Bioscience's OCF Margin % too high?
RBC Bioscience's current OCF Margin % of 29.00% is 122% above median its 10-year median of 13.05. Based on the distribution chart, RBC Bioscience ranks #165 out of 950 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, RBC Bioscience has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RBC Bioscience's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, RBC Bioscience ranks #165 out of 950 companies for OCF Margin %. This places RBC Bioscience in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on RBC Bioscience and its competitors. RBC Bioscience's current OCF Margin % is 29.00%, which is 122% above median its own 10-year median of 13.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Bioscience stock overvalued right now?
Based on GuruFocus' analysis, RBC Bioscience (ROCO:6848) is currently considered Fairly Valued. The stock's GF Value™ is NT$19.91, compared to a current price of NT$20.50 — trading 3% above its estimated fair value. The current OCF Margin % is 29.00%, which is 122% above median its 10-year median of 13.05. RBC Bioscience's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For RBC Bioscience (ROCO:6848), the current OCF Margin % is 29.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RBC Bioscience (ROCO:6848) Overvalued in 2026?

Based on GuruFocus' analysis, RBC Bioscience stock appears to be overvalued. The current stock price of NT$20.50 is trading 3% above its estimated GF Value™ of NT$19.91. GuruFocus considers RBC Bioscience to be Fairly Valued.

Key valuation signals for ROCO:6848:

  • OCF Margin %: 29.00% (122% above median its 10-year median of 13.05)
  • GF Value™: NT$19.91 vs. price of NT$20.50 (3% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6848 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RBC Bioscience Business Description

Address No. 15, Qiaohe Road, 15th Floor, Zhonghe District, New Taipei City, TWN, 23145
RBC Bioscience Corp is a bio-sciences company. Its products include the manufacture and sale of molecular biological medical diagnosis and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues.
76GF Score

Get the complete analysis for ROCO:6848

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.50
Price
NT$19.91
GF Value